‘Zoloft’ Tagged Posts

Zoloft Parody



Rottenstein Law Group Learns of Zoloft Manufacturer’s Motion to Consolidate 59 Cases into One Multidistrict Litigation


New York, NY (PRWEB) February 01, 2012

Pfizer filed the motion on Jan. 18 under the following multi-district litigation number: MDR 2342. The motion’s stipulations and some background on the cases that the motion seeks to consolidate are outlined in a Jan. 20, 2012, article on Law.com.

As the Law.com article states, all of the cases in the group that is the subject of Pfizer’s motion allege that the children of mothers who took Zoloft during their pregnancies suffered birth defects as a result of that Zoloft use. Pfizer’s motion requests that the consolidated multidistrict litigation of those cases take place in the Southern District of New York, where Pfizer is headquartered. Since New York has three international airports at its disposal, Pfizer asserts in its motion, New York would be a convenient location for the cases’ plaintiffs, who are scattered throughout the country.

Pfizer named the Northern District of Mississippi, the Southern District of Mississippi or the Northern District of Ohio as alternative locations for the proposed multidistrict litigation, stating that those locations would also be convenient for the cases’ many plaintiffs.

Almost 50 of the cases that are the subject of Pfizer’s motion had been removed to the U.S. District Court for the Eastern District of Pennsylvania, according to Law.com. “Pfizer argued in the motion [to consolidate the cases into one multiditsrict litigation] that in the Pennsylvania cases plaintiffs have created an artificial concentration of cases in Pennsylvania by … fraudulently joining Wolters Kluwer Health, a Pennsylvania corporation, as a defendant, in order to defeat diversity jurisdiction,” the Law.com article states.

“The plaintiffs’ theory against Wolters Kluwer Health is that it was negligent in the publication of the risks and benefits of using Zoloft during pregnancy in its patient education monographs,” the Law.com article continues. “Pfizer argues that the division that published the monographs, Medi-Span, is headquartered in Indiana and has offices in Missouri, so Pennsylvania has no ‘real nexus’ to the out-of-state plaintiffs, defendants that the drug company argues are located elsewhere and the underlying allegedly negligent transactions.”

RLGs Zoloft Lawsuit and Birth Defects Information Center, at http://www.zoloftsertralinebirthdefects.com, has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about Zoloft and the dangers of the drug. The Rottenstein Law Group, a personal injury firm, encourages visitors to link to its sites from their own blogs and websites to spread information about defective medical products and dangerous drugs.

# # #

As Zoloft Lawsuits Mount, New Study Ties Zoloft and Other SSRI Antidepressants to Higher Risk of Bleeding in Warfarin Users


New York, New York (PRWEB) November 11, 2012

As Zoloft lawsuits continue to move forward, a new study has found evidence that warfarin patients who also take Zoloft and other selective serotonin reuptake inhibitor (SSRI) antidepressants may face an increased risk of bleeding, Bernstein Liebhard LLP reports. According to the study, which was presented at the American Heart Associations annual meeting, there was a 60 percent higher risk of major hemorrhage in patients that were taking SSRI antidepressants, like Zoloft, and warfarin, compared to those who werent taking an SSRI.*

The study looked at medical records from 13,000 atrial fibrillation patients, 9,200 of whom were being treated with warfarin. The warfarin patients were divided into three groups: those who were taking no antidepressants, patients who were taking SSRIs and patients who were taking older tricyclic antidepressants According to the study authors, there was no statistically significant difference in bleeding risk in those patients taking tricyclic antidepressants and warfarin.

This study is just further evidence of the serious risks that sometimes accompany the use of Zoloft and other SSRI antidepressants, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is currently offering free Zoloft lawsuit consultations to victims of birth defects and other alleged Zoloft side effects.

Zoloft Lawsuits

Zoloft is an SSRI antidepressant marketed by Pfizer Inc. that is used to treat major depression, obsessive-compulsive disorder, panic disorder, and anxiety disorders. In April 2012, the U.S. Judicial Panel on Multidistrict Litigation transferred all federally-filed Zoloft lawsuits to the U.S. District Court, Eastern District of Pennsylvania as part of a consolidated litigation entitled In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation (MDL 2342). All of the Zoloft lawsuits pending in the litigation involve allegations that the antidepressant causes birth defects in children when their mothers ingest the drug while pregnant. According to Pretrial Order No. 10, U.S. District Judge Cynthia Rufe has scheduled the Zoloft litigations next status conference for November 19th.**

Victims of alleged Zoloft side effects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about Zoloft lawsuits and alleged Zoloft birth defects, please visit Bernstein Liebhard LLPs website. For additional information, contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.

** paed.uscourts.gov/documents/MDL/MDL2342/PTO10.pdf

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

(877) 779-1414


Mindset – Zoloft (Hazem Beltagui Pres H4Z3 Remix)


The Law Firm Alonso Krangle LLP Launches Investigation of Birth Defects Possibly Due to Side Effects From The Antidepressant Zoloft


Melville, NY (PRWEB) February 22, 2012

Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, announce the launch of an investigation into alleged Zoloft birth defects, side effects. Their firm is currently offering free Zoloft lawsuit evaluations to any family who believes their childs birth defect was the result of their mothers use of Zoloft during pregnancy. Birth defect side effects allegedly associated with the use of Zoloft and other selective serotonin reuptake inhibitor (SSRI) antidepressants Celexa, Lexapro, Paxil, Prozac, Effexor and Lexapro include:

Atrial and ventrical septal heart defects (ASD/VSD)

Hypoplastic Left Heart Syndrome (HLHS)

Transposition of Great Arteries

Coarctation of the Aorta (CoA)

Tetralogy of Fallot (TOF)

Skull defects, Craniosynostosis

Persistent Pulmonary Hypertension of the Newborn


Pulmonary atresia

Pulmonary stenosis

Neural tube defects of the brain and spinal cord

Anal Atresia

Limb reduction defects

Clubbed Foot

Oral Clefts, Cleft Lip and Cleft Palate

In addition to Zoloft, the defective drug lawyers at Alonso Krangle LLP are also investigating possible links between other SSRI antidepressants and birth defects. Additional medications currently under investigation include:







To discuss a potential Zoloft or SSRI antidepressant birth defect lawsuit with one of the experienced and compassionate defective drug lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

What is Zoloft?

Zoloft is an SSRI antidepressant marketed by Pfizer Inc. that was approved by the U.S. Food & Drug Administration (FDA) in 1991. Zoloft is used to treat major depression, obsessive-compulsive disorder, panic disorder and anxiety disorders. SSRI antidepressants like Zoloft relieve patients system by altering the balance of the serotonin in the brain.

According to the [mayoclinic.com/health/ssris/MH00066] Mayo Clinic, SSRIs are the most commonly prescribed antidepressants. However, a number of studies have linked SSRI antidepressants, including Zoloft, to an increased risk of birth defects when they are used during pregnancy, especially in the first trimester, when many expectant mothers do not know they are pregnant. In 2006, a study published by the [nejm.org/doi/full/10.1056/NEJMoa052744] New England Journal of Medicine found that women who used SSRIs like Zoloft after the 20th week of pregnancy were six times more likely to give birth to an infant with persistent pulmonary hypertension of the newborn (PPHN). In another study published in the [nejm.org/doi/full/10.1056/NEJMoa067407] New England Journal of Medicine in 2007, researchers found that babies born to women who used Zoloft during the first trimester of pregnancy were twice as likely to suffer heart-related birth defects. The most common heart defects seen in that study were ventricular outflow defects and septal defects.

Just last month, a study conducted by researchers at Swedens Karolinska Institutace found that children born to women who took SSRI antidepressants, including Zoloft, face double the risk of having a baby born with PPHN, a life-threatening lung condition. The study, published in the [bmj.com/content/344/bmj.d8012] British Medical Journal, involved 1.6 million live births in five Nordic countries that occurred from 1996 through 2007.

Zoloft Lawsuits

At least 59 lawsuits have been filed in courts throughout the U.S. alleging a mothers use of Zoloft was responsible for a childs birth defects. Recently, Pfizer filed a motion with the U.S. Judicial Panel on Multidistrict Litigation seeking the consolidation of all Zoloft birth defect lawsuits in a multidistrict litigation (MDL No. 2342). Pfizer requested that the proposed Zoloft MDL be transferred to the U.S. District Court for the Southern District of New York or, alternatively, the U.S. District Court for the Northern District of Mississippi, the U.S. District Court for the Southern District of Mississippi, or the U.S. District Court for the Northern District of Ohio. According to a [jpml.uscourts.gov/Hearing_Order-3-29-12.pdf] notice issued on February 13, the Panel will hear oral arguments on Pfizers motion on March 29 in San Diego, California.

There is still time for families who believe Zoloft or another SSRI antidepressant caused their childs birth defect to file their own lawsuits against the makers of these medications. To discuss a potential claim with one of the experienced and compassionate Zoloft birth defect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website http://www.FightForVictims.com

About Alonso Krangle LLP

Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact: Alonso Krangle LLP

445 Broad Hollow Road

Suite 205

Melville, New York


Toll-free 1-800-403-6191

Tel: 516-350-5555

Fax: 516-350-5554